References
- ShimamatsuKInamasuHA safe and easy introduction of darbepoetin-alpha in patients receiving maintenance hemodialysis and epoetin monotherapy: a “half-and-half” combination therapyCurr Ther Res2013745824384988
- ShimamatsuKExperience with iv iron chondroitin-sulphate colloid in Japanese haemodialysis patientsNephrol Dial Transplant19981310539568888
- ShimamatsuKLow-dose maintenance supplementation of intravenous iron chondroitin-sulfate colloid in hemodialysis patients: a 3-year follow-upDial Transplant200332595598
- MitsuikiKHaradaAMiyataYReduction of recombinant human erythropoietin maintenance dose by supplementation with a low-dose iron preparation, given intravenouslyClin Exp Nephrol20015228233
- LocatelliFOlivaresJWalkerREuropean/Australian NESP 980202 Study GroupNovel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiencyKidney Int20016074174711473657
- BesarabABoltonWKBrowneJKThe effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetinN Engl J Med19983395845909718377
- DrüekeTBLocatelliFClyneNCREATE InvestigatorsNormalization of hemoglobin level in patients with chronic kidney disease and anemiaN Engl J Med20063552071208517108342
- SinghAKSzczechLTangKLCHOIR InvestigatorsCorrection of anemia with epoetin-alfa in chronic kidney diseaseN Engl J Med20063552085209817108343
- PfefferMABurdmannEAChenC-YA trial of darbepoetin alfa in type 2 diabetes and chronic kidney diseaseN Engl J Med20093612019203219880844
- KoulourisIAlfayezMTrikalinosTABalkEMJaberBLDose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysisAm J Kidney Dis201361445622921639
- McMurrayJJVParfreyPSAdamsonJWKDIGO Clinical Practice Guideline for anemia in chronic kidney diseaseKidney Int Suppl20122279335
- National Kidney FoundationKDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney diseaseAm J Kidney Dis200647Suppl 3S11S14616678659
- LocatelliFAljamaPBárányPRevised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Section II. Targets for anaemia treatmentNephrol Dial Transplant200419Suppl 2ii6ii15
- PisoniRLBragg-GreshamJLFullerDSFacility-level interpatients hemoglobin variability in hemodialysis centers participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS): associations with mortality, patient characteristics, and facility practicesAm J Kidney Dis20115726627521251541
- YangWIsraniRKBrunelliSMHemoglobin variability and mortality in ESRAJ Am Soc Nephrol2007183164317018003781